Wells Fargo Upgrades RxSight Inc. (RXST) to Overweight

Wells Fargo analyst Lawrence Biegelsen upgraded RxSight Inc. (NASDAQ: RXST) from Equal Weight to Overweight with a price target of $42.00.

For an analyst ratings summary and ratings history on RxSight Inc. click here. For more ratings news on RxSight Inc. click here.

Shares of RxSight Inc. closed at $37.53 yesterday.

You May Also Be Interested In

• William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
• Morgan Stanley Upgrades TWFG Insurance (TWFG) to Overweight
• Nomura/Instinet Upgrades Shenzhen T&S Communication (300570:CH) to Buy